Login

Forgot password?
Sign up today and your first download is free.
REGISTER

Rx Drugs

June 18, 2019 | Daily News

Some biologics experts are perplexed by the Trump administration’s argument that subjecting biologics products to United States Pharmacopeia (USP) monographs would hamper innovation.

June 18, 2019 | Daily News

Americans for Safe Access and data company Aurelius Data Inc. have partnered to develop a research platform that will compile use, perception and biometric data on consumers who are using cannabis products to help their medical conditions, and will make those insights available in a subscription-based database that allows users to see what regimens patients are using.

June 18, 2019 | Daily News

Senate health committee Chair Lamar Alexander (R-TN) said Tuesday (June 18) that his committee will mark up its bipartisan legislation to lower health costs next week.

June 17, 2019 | Daily News

The Pharmaceutical Research and Manufacturers of America is running attack ads that say AARP cares more about insurers than seniors, but AARP says the poll that PhRMA is relying on for that message is so misleading that the seniors’ group filed a complaint with the organization that guards against push polling.

June 17, 2019 | Daily News

Former FDA Commissioner Scott Gottlieb named payer tactics as one of the biggest obstacles facing the gene therapy space, as novel drugs seeking coverage after receiving FDA approval are often viewed by payers as not having enough data on which to base a coverage decision.

June 14, 2019 | Daily News

Amgen, Merck and Eli Lilly on Friday (June 14) filed a lawsuit to block the Trump administration from forcing drug makers to disclose drug prices in advertisements.

June 14, 2019 | Daily News

Former FDA Commissioner Scott Gottlieb defended drug maker Pfizer’s choice to not investigate signals that its anti-inflammatory drug Enbrel appeared to reduce the risk of Alzheimer’s, as the Washington Post reported on June 4.

June 14, 2019 | Daily News

Congressional Medicaid advisers on Friday (June 14) released their June report recommending statutory changes intended to reduce government spending on prescription drugs in Medicaid, give states more time to cover new drugs, and tighten the definition of the so-called Medicaid shortfall.

June 14, 2019 | Daily News

CMS will allow Washington to enter outcomes-based contracts with drug makers in Medicaid under a State Plan Amendment that facilitates use of a subscription model for purchasing hepatitis C drugs, the agency announced Wednesday (June 12).

June 13, 2019 | Daily News

Drug pricing is the top priority for House liberals for the next two to four weeks as they try to pull policies to the left before Speaker Nancy Pelosi (D-CA) brings legislation to the floor, Reps. Pramila Jayapal (D-WA) and Mark Pocan (D-WI) said Wednesday (June 12).

June 13, 2019 | Daily News

The United States Pharmacopeia, backed by generic drug makers and multiple pharmacist groups, has launched a full-scale effort to quash a proposal by the Senate health committee and Trump administration to remove biologics from USP monograph standards, arguing the proposal would reduce confidence in biosimilars.

June 13, 2019 | Daily News

A device industry lawyer said FDA’s software precertification test plan could help FDA win the statutory authority it needs to implement the pre-cert program, as it could give lawmakers the evidence they need to conclude the program achieves the same level of safety validation as FDA’s traditional review pathways.

June 13, 2019 | Daily News

FDA’s decision to center its compounding regulatory program in the drug center’s compliance office represents a shift to a more enforcement-focused approach to compounding, according to a drug compounding lawyer.

June 13, 2019 | Daily News

FDA on Wednesday (June 12) issued a call for stakeholders to send pathogen samples to the agency in order to help build a database to support the rapid identification of infectious diseases in patients.

June 13, 2019 | Daily News

As part of their investigation into the dangers of illicit fentanyl, much of which comes from China, a bipartisan group of House Energy & Commerce Committee leaders wrote to FDA Acting Commissioner Ned Sharpless and heads of five other federal agencies to request briefings on the effect the opioid epidemic is having on public health and on their solutions for stopping the flow of illicit fentanyl into the United States.

June 11, 2019 | Daily News

Florida GOP Gov. Ron DeSantis on Tuesday (June 11) signed the state legislature’s bill that orders Florida to create a Canadian prescription drug importation program. Florida is the third state to pass such a law, and the first to enact one law passed by a Republican-dominated legislature.

June 11, 2019 | Daily News

White House budget officials began reviewing Tuesday (June 11) HHS’ final version of a rule to ban drug rebates in Medicare and Medicaid that aren’t shared at the point of sale.

June 10, 2019 | Daily News

FDA hopes to encourage more diversity in clinical trials through draft guidance that lays out how drug and biologic sponsors can broaden eligibility criteria, avoid unnecessary exclusions and reduce burdens on trial participants.

June 07, 2019 | Daily News

Connecticut lawmakers’ effort to pass a sweeping health reform bill collapsed in the state’s senate late Wednesday (June 5), the final day of the session.

June 07, 2019 | Daily News

Opioid maker Insys Therapeutics, which manufacturers fentanyl product Subsys, will plead guilty to five counts of mail fraud, pay millions in fines and pay to settle allegations that it violated the False Claims Act, the Department of Justice (DOJ) announced Wednesday (June 5).

Pages